Target Name: CYB5R1
NCBI ID: G51706
Review Report on CYB5R1 Target / Biomarker Content of Review Report on CYB5R1 Target / Biomarker
CYB5R1
Other Name(s): NADH-cytochrome b5 reductase 1 | b5R.1 | Cytochrome b5 reductase 1 | NAD(P)H:quinone oxidoreductase type 3 polypeptide A2 | NAD(P)H:quinone oxidoreductase type 3, polypeptide A2 | NQO3A2 | cytochrome b5 reductase 1 | B5R1 | B5R2 | NB5R1_HUMAN | Humb5R2 | humb5R2 | B5R.1

CYB5R1: Key Enzyme in Electron Transport Chain

CYB5R1, also known as NADH-cytochrome b5 reductase 1, is a gene that encodes a protein in the cytoplasm of all living cells. The cytoplasm is the fluid that surrounds the nucleus and contains the cell's mitochondria, where energy metabolism takes place. CYB5R1 is a key enzyme in the electron transport chain, which is a critical part of the cell's energy production process.

The CYB5R1 gene was first identified in 1995 and has since been extensively studied. It is located on chromosome 16 and has been shown to be expressed in a wide variety of tissues and cells, including muscle, heart, brain, and cancer cells. CYB5R1 is a cytoplasmic protein, which means that it is located in the cytoplasm rather than the nucleus.

One of the key functions of CYB5R1 is its role in the electron transport chain. The electron transport chain is a series of proteins that transport electrons from the cytoplasm to the nucleus. This process is essential for the production of ATP, or adenosine triphosphate, which is the energy currency of the cell.

CYB5R1 is a key enzyme in the electron transport chain, as it helps to regulate the flow of electrons from the cytoplasm to the nucleus. It does this by participating in the cytoplasmic transport of NAD+, or nicotinamide adenine dinucleotide, which is a coenzyme that plays a central role in the electron transport chain.

NAD+ is a crucial coenzyme for the electron transport chain, as it helps to carry electrons from the cytoplasm to the nucleus. CYB5R1 helps to regulate the transport of NAD+ by participating in the transfer of electrons from the cytoplasm to the nucleus. This process is critical for the production of ATP, as the electrons that are transferred from the cytoplasm to the nucleus are used to generate ATP.

In addition to its role in the electron transport chain, CYB5R1 has also been shown to play a number of other roles in the cell. For example, it has been shown to be involved in the regulation of cell growth, and in the development and progression of cancer. CYB5R1 has also been shown to play a role in the regulation of cell death, and has been linked to the development of neurodegenerative diseases.

CYB5R1 is also a potential drug target, as its role in the electron transport chain makes it a promising target for therapies that target the electron transport chain. For example, inhibitors of CYB5R1 have been shown to be effective in treating a variety of conditions, including cancer, heart disease, and neurological disorders.

In conclusion, CYB5R1 is a key protein that plays a critical role in the electron transport chain and is a potential drug target. Further research is needed to fully understand its functions and potential as a drug.

Protein Name: Cytochrome B5 Reductase 1

Functions: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction

The "CYB5R1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB5R1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CYB5R2 | CYB5R3 | CYB5R4 | CYB5RL | CYBA | CYBB | CYBC1 | CYBRD1 | CYC1 | Cyclin | Cyclin A | Cyclin B | Cyclin D | Cyclin D2-CDK4 complex | Cyclin-dependent kinase | Cyclin-dependent kinase inhibitor | Cyclooxygenase (COX) | Cyclophilins | CYCS | CYCSP25 | CYCSP34 | CYCSP38 | CYCSP51 | CYCSP52 | CYCSP53 | CYCSP55 | CYFIP1 | CYFIP2 | CYGB | CYLC1 | CYLC2 | CYLD | CYLD-AS1 | CYMP | CYP11A1 | CYP11B1 | CYP11B2 | CYP17A1 | CYP19A1 | CYP1A1 | CYP1A2 | CYP1B1 | CYP1B1-AS1 | CYP20A1 | CYP21A1P | CYP21A2 | CYP24A1 | CYP26A1 | CYP26B1 | CYP26C1 | CYP27A1 | CYP27B1 | CYP27C1 | CYP2A13 | CYP2A6 | CYP2A7 | CYP2A7P1 | CYP2B6 | CYP2B7P | CYP2C18 | CYP2C19 | CYP2C61P | CYP2C8 | CYP2C9 | CYP2D6 | CYP2D7 | CYP2D8P | CYP2E1 | CYP2F1 | CYP2F2P | CYP2G1P | CYP2J2 | CYP2R1 | CYP2S1 | CYP2T1P | CYP2U1 | CYP2U1-AS1 | CYP2W1 | CYP39A1 | CYP3A4 | CYP3A43 | CYP3A5 | CYP3A51P | CYP3A7 | CYP3A7-CYP3A51P | CYP3AP2 | CYP46A1 | CYP4A11 | CYP4A22 | CYP4B1 | CYP4F11 | CYP4F12 | CYP4F2 | CYP4F22 | CYP4F26P | CYP4F29P | CYP4F3 | CYP4F30P | CYP4F34P | CYP4F35P